Clinical Trial Update: G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the use of granulocyte colony-stimulating factor (G-CSF) to prevent chemotherapy-induced neutropenia in patients with solid tumors; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Neutropenia

Drugs mentioned

• Filgrastim (filgrastim)
• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Chemotherapeutic Agent Toxicity, Neutropenia | Phase 3 | Status: COMPLETED